- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05116358
Phase II Study - Trial of a Phototherapy Light Device to Improve Sleep Health (PHOTONS)
1 november 2021 uppdaterad av: MICHAEL A GRANDNER, University of Arizona
There are few devices currently on the market claiming to improve sleep.
This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night.
Studieöversikt
Detaljerad beskrivning
This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night.
Phototherapy has been shown to improve chronic pain, cerebral blood flow, neurological function, and capillary growth in skeletal muscle.
A device worn at night may improve sleep onset, total sleep time, or modify sleep architecture.
Improved cardiovascular function may facilitate a decrease in core body temperature needed for sleep onset.
Relaxation from direct heat may help to decrease cortisol levels, thus reducing the number of night-time arousals.
It may also decrease circulating levels of norepinephrine (NE), one of the main neurotransmitters involved in arousal.
The aim of this study is to evaluate if the device worn leads to greater next-day wellbeing and cognitive function as a result of increased slow-wave activity.
Studietyp
Interventionell
Inskrivning (Förväntat)
30
Fas
- Fas 2
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Arizona
-
Tucson, Arizona, Förenta staterna, 85719
- Rekrytering
- Department of Psychiatry, University of Arizona
-
Kontakt:
- Michael A Grandner, PhD
- Telefonnummer: 520-626-6246
- E-post: grandner@email.arizona.edu
-
Kontakt:
- Chloe CA Wills
- Telefonnummer: 520 626 1737
- E-post: chloecawills@psychiatry.arizona.edu
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
30 år till 60 år (Vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Between the ages of 18 and 60 years old
- Able to read and write fluently in English
- Access to a mobile device for video calls, online questionnaires, syncing devices, and communication with study staff
- Access to a residential mailing address for shipping study materials
- Exhibit a score of >8 on the Insomnia Severity Index
- Self-report that they have a problem with their sleep that they wish to improve
Exclusion Criteria:
- Have a moderate to severe current sleep disorder
- Have a current psychiatric disorder
- Are taking medication that would interfere with sleep, including beta blockers, antidepressants, antianxiety medications, hypnotics, or stimulants
- Have a medical condition that would interfere with their ability to complete all study procedures or would render measurements invalid (e.g., some autoimmune conditions, cardiac conditions, endocrine conditions, or chronic pain conditions)
- Exhibit a regular sleep schedule, where bed and wake times are kept within a 2-hour window 7 days per week
- Exhibit a regular sleep schedule during the night, beginning no earlier than 9pm and ending no later than 10am
- Have not engaged in shift work for the past month, and will refrain from shift work during the study
- Are unable to restrict alcohol consumption to no more than 2 drinks within 4 hours of sleep
- Are unable to restrict caffeine use to no coffee or caffeinated beverages after 12pm during the study
- Regularly smoke or use other tobacco products
- Regularly use cannabis-derived medicinal products
- Are pregnant
- Are a full-time caregiver to an individual that requires attending during the evening and night
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Active
An active phototherapy device
|
The active phototherapy device will emit light
|
Sham Comparator: Sham (Placebo)
An inactive device
|
The active phototherapy device will emit light
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in subjective rating of the device across a 3-week intervention
Tidsram: Change in subjective rating of the device from baseline (pre; Day 0) to after 21 days of wearing it (post)
|
There will be a subjective rating of the phototherapy device using a series of questions assessing device's effect on sleep and next-day function at the end of the trial.
|
Change in subjective rating of the device from baseline (pre; Day 0) to after 21 days of wearing it (post)
|
Change in Insomnia Severity Index (ISI) scores across a 3-week intervention
Tidsram: Change from baseline over the course of the study (after 21 days of wearing the device)
|
The ISI is a 7-item insomnia screening tool that is the gold standard for quantifying severity of clinical insomnia symptoms.
|
Change from baseline over the course of the study (after 21 days of wearing the device)
|
Change in objective sleep efficiency across a 3-week intervention
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Objective sleep efficiency will be measured with a wearable device (Oura ring) that is worn for the duration of the study and captures sleep and wake data using actigraphy.
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in mean sleep latency assessed using sleep diaries
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Sleep latency, or time taken to fall asleep, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean sleep latency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in Karolinska Sleepiness Scale (KSS) score
Tidsram: Change from before intervention (pre) to post three weeks of wearing the phototherapy device (Day 21)..
|
The Karolinska Sleepiness Scale (KSS) measures situational sleepiness on a 9-point scale
|
Change from before intervention (pre) to post three weeks of wearing the phototherapy device (Day 21)..
|
Circadian Energy Scale (CIRENS) score
Tidsram: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
CIRENS is a very short and simple chronotype measurement tool based on energy.
The CIRENS consists of two introspective questions about the usual energy level (very low, low, moderate, high, or very high, scored 1 to 5) in the morning and in the evening.
The difference between energy level scores (-4 to 4) felt by respondents in the evening and morning defines the chronotype score and classification.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Positive and Negative Affect Scales (PANAS) Positive Affect
Tidsram: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Positive and Negative Affect Scales are brief screening measures that assess both positive and negative emotional experiences.
This scale will allow for separate assessment of impact on positive mood.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Positive and Negative Affect Scales (PANAS) Negative Affect
Tidsram: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Positive and Negative Affect Scales are brief screening measures that assess both positive and negative emotional experiences.
This scale will allow for separate assessment of impact on negative mood.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Fatigue Severity Scale (FSS) across a three-week intervention
Tidsram: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Fatigue Severity Scale (FSS) is a well-validated 9-item clinical measure that assesses overall levels of mental and physical fatigue, with answers ranging from 1- "Strongly Disagree" to 7-"Strongly Agree".
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Profile of Mood States (POMS) across a three week intervention
Tidsram: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.
The POMS measures six different dimensions of mood swings over a period of time.
These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment.
A total score will be evaluated in addition to the individual items.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Wake After Sleep Onset (WASO) assessed using morning sleep diaries over the duration of the study
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Wake after sleep onset (WASO), or the number of nocturnal awakenings, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean WASO during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in sleep efficiency assessed using morning sleep diaries over the duration of the study
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Sleep efficiency, or the amount of time spent asleep during a sleep opportunity, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean sleep efficiency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in total sleep time assessed using morning sleep diaries over the duration of the study
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Total sleep time will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean total sleep time during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in morning refreshed feeling assessed using morning sleep diaries over the duration of the study
Tidsram: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Morning refreshed feeling will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean refreshed feeling during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
2 september 2021
Primärt slutförande (Förväntat)
30 januari 2022
Avslutad studie (Förväntat)
30 januari 2022
Studieregistreringsdatum
Först inskickad
1 november 2021
Först inskickad som uppfyllde QC-kriterierna
1 november 2021
Första postat (Faktisk)
11 november 2021
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
11 november 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
1 november 2021
Senast verifierad
1 november 2021
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 2012256803
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
OBESLUTSAM
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Sova
-
University of Wisconsin, MadisonPhilips HealthcareAvslutadSömn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
National University of SingaporeRekryteringReduktion av skärmanvändning + Sleep Extension | FrilevandeSingapore
-
Northwell HealthJazz PharmaceuticalsRekryteringElektrisk status Epilepticus of Slow-Wave SleepFörenta staterna
-
Eisai Inc.AvslutadOregelbunden Sleep Wake Rhythm DisorderFörenta staterna
-
Brigham and Women's HospitalAktiv, inte rekryterandeSömnstörningar, inneboende | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm...Förenta staterna
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRekryteringSömnstörningar, inneboende | Vakna sömnstörningar | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm Sömnstörning och andra villkorFörenta staterna
-
Tyco Healthcare GroupOkänd
-
Brigham and Women's HospitalStanford UniversityRekryteringVakna sömnstörningar | Sömnstörning | Sömnstörningar, dygnsrytm | Dygnsrytmstörningar | Circadian Rhythm Sömnstörning | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndromFörenta staterna
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheAvslutadRolandsk epilepsi | Landau-Kleffners syndrom | Nattlig frontallobsepilepsi | Elektrisk status Epilepticus under Slow Wave SleepNederländerna
Kliniska prövningar på Phototherapy device
-
Spaulding Rehabilitation HospitalAvslutad
-
PhotoPharmics, Inc.University of RochesterRekryteringParkinsons sjukdomFörenta staterna
-
Centre Hospitalier Universitaire de NīmesAvslutad
-
University of Santiago de CompostelaAvslutadHuvud- och halscancer | Oral cancer | Oral mukosit | Osteoradionekros | Hyposalivation | Osteonekros på grund av droger, käke | Osteonekros, bisfosfonatSpanien